Phase II study of S-1 combined with oxaliplatin as therapy for patients with metastatic biliary tract cancer: influence of the CYP2A6 polymorphism on pharmacokinetics and clinical...

por Kim, K-p, Jang, G, Hong, Y S, Lim, H-S, Bae, K-s, Kim, H-S, Lee, S S, Shin, J-G, Lee, J-L, Ryu, M-H, Chang, H-M, Kang, Y-K, Kim, T W
Publicado 2011

CYP2A6 and ERCC1 polymorphisms correlate with efficacy of S-1 plus cisplatin in metastatic gastric cancer patients

por Park, S R, Kong, S-Y, Nam, B-H, Choi, I J, Kim, C G, Lee, J Y, Cho, S J, Kim, Y W, Ryu, K W, Lee, J H, Rhee, J, Park, Y-I, Kim, N K
Publicado 2011

Meta-analysis of immunohistochemical prognostic markers in resected pancreatic cancer

por Smith, R A, Tang, J, Tudur-Smith, C, Neoptolemos, J P, Ghaneh, P
Publicado 2011

Body mass index in early adulthood and colorectal cancer risk for carriers and non-carriers of germline mutations in DNA mismatch repair genes

por Win, A K, Dowty, J G, English, D R, Campbell, P T, Young, J P, Winship, I, Macrae, F A, Lipton, L, Parry, S, Young, G P, Buchanan, D D, Martínez, M E, Jacobs, E T, Ahnen, D J, Haile, R W, Casey, G, Baron, J A, Lindor, N M, Thibodeau, S N, Newcomb, P A, Potter, J D, Le Marchand, L, Gallinger, S, Hopper, J L, Jenkins, M A
Publicado 2011

Correlation of capecitabine-induced skin toxicity with treatment efficacy in patients with metastatic colorectal cancer: results from the German AIO KRK-0104 trial

por Stintzing, S, Fischer von Weikersthal, L, Vehling-Kaiser, U, Stauch, M, Hass, H G, Dietzfelbinger, H, Oruzio, D, Klein, S, Zellmann, K, Decker, T, Schulze, M, Abenhardt, W, Puchtler, G, Kappauf, H, Mittermüller, J, Haberl, C, Giessen, C, Moosmann, N, Heinemann, V
Publicado 2011

Specific detection of OCT3/4 isoform A/B/B1 expression in solid (germ cell) tumours and cell lines: confirmation of OCT3/4 specificity for germ cell tumours

por Rijlaarsdam, M A, van Herk, H A D M, Gillis, A J M, Stoop, H, Jenster, G, Martens, J, van Leenders, G J L H, Dinjens, W, Hoogland, A M, Timmermans, M, Looijenga, L H J
Publicado 2011

A truncated form of CD9-partner 1 (CD9P-1), GS-168AT2, potently inhibits in vivo tumour-induced angiogenesis and tumour growth

por Colin, S, Guilmain, W, Creoff, E, Schneider, C, Steverlynck, C, Bongaerts, M, Legrand, E, Vannier, J P, Muraine, M, Vasse, M, Al-Mahmood, S
Publicado 2011

Short-time repeat high-risk HPV testing by self-sampling for screening of cervical cancer

por Gyllensten, U, Sanner, K, Gustavsson, I, Lindell, M, Wikström, I, Wilander, E
Publicado 2011

Phase I study of irinotecan and gefitinib in patients with gefitinib treatment failure for non-small cell lung cancer

por Horiike, A, Kudo, K, Miyauchi, E, Ohyanagi, F, Kasahara, K, Horai, T, Nishio, M
Publicado 2011

Frequent loss of the AXIN1 locus but absence of AXIN1 gene mutations in adenocarcinomas of the gastro-oesophageal junction with nuclear β-catenin expression

por Koppert, L B, van der Velden, A W, van de Wetering, M, Abbou, M, van den Ouweland, A M W, Tilanus, H W, Wijnhoven, B P L, Dinjens, W N M
Publicado 2004

Oral contraceptive use and reproductive factors and risk of ovarian cancer in the European Prospective Investigation into Cancer and Nutrition

por Tsilidis, K K, Allen, N E, Key, T J, Dossus, L, Lukanova, A, Bakken, K, Lund, E, Fournier, A, Overvad, K, Hansen, L, Tjønneland, A, Fedirko, V, Rinaldi, S, Romieu, I, Clavel-Chapelon, F, Engel, P, Kaaks, R, Schütze, M, Steffen, A, Bamia, C, Trichopoulou, A, Zylis, D, Masala, G, Pala, V, Galasso, R, Tumino, R, Sacerdote, C, Bueno-de-Mesquita, H B, van Duijnhoven, F J B, Braem, M G M, Onland-Moret, N C, Gram, I T, Rodríguez, L, Travier, N, Sánchez, M-J, Huerta, J M, Ardanaz, E, Larrañaga, N, Jirström, K, Manjer, J, Idahl, A, Ohlson, N, Khaw, K-T, Wareham, N, Mouw, T, Norat, T, Riboli, E
Publicado 2011

Molecular characterisation of formalin-fixed paraffin-embedded (FFPE) breast tumour specimens using a custom 512-gene breast cancer bead array-based platform

por Abramovitz, M, Barwick, B G, Willis, S, Young, B, Catzavelos, C, Li, Z, Kodani, M, Tang, W, Bouzyk, M, Moreno, C S, Leyland-Jones, B
Publicado 2011

Therapy-Induced Changes in CXCR4 Expression in Tumor Xenografts Can Be Monitored Noninvasively with N-[(11)C]Methyl-AMD3465 PET

por Hartimath, SV, Draghiciu, O., Daemen, T, Nijman, H.W., van Waarde, A., Dierckx, R.A.J.O., de Vries, E.F.J.
Publicado 2019

Informed Consent in Pragmatic Trials: Results from a Survey of Trials published 2014–2019

por Zhang, Jennifer Zhe, Nicholls, Stuart G, Carroll, Kelly, Nix, Hayden P, Goldstein, Cory E, Hey, Spencer P, Brehaut, Jamie C, McLean, Paul C, Weijer, Charles, Fergusson, Dean A, Taljaard, Monica
Publicado 2021

Staging investigations for oesophageal cancer: a meta-analysis

por van Vliet, E P M, Heijenbrok-Kal, M H, Hunink, M G M, Kuipers, E J, Siersema, P D
Publicado 2008

Clinical outcome and prognostic factors for patients treated within the context of a phase I study: the Royal Marsden Hospital experience

por Arkenau, H-T, Olmos, D, Ang, J E, de Bono, J, Judson, I, Kaye, S
Publicado 2008

Assessment of 1183 screen-detected, category 3B, circumscribed masses by cytology and core biopsy with long-term follow up data

por Farshid, G, Downey, P, Gill, P G, Pieterse, S
Publicado 2008

Detection of distant metastases in patients with oesophageal or gastric cardia cancer: a diagnostic decision analysis

por van Vliet, E P M, Steyerberg, E W, Eijkemans, M J C, Kuipers, E J, Siersema, P D
Publicado 2007

Neoadjuvant chemotherapy prior to preoperative chemoradiation or radiation in rectal cancer: should we be more cautious?

por Glynne-Jones, R, Grainger, J, Harrison, M, Ostler, P, Makris, A
Publicado 2006

Potentiation of the anticancer effect of valproic acid, an antiepileptic agent with histone deacetylase inhibitory activity, by the kinase inhibitor Staurosporine or its clinically...

por Yeow, W-S, Ziauddin, M F, Maxhimer, J B, Shamimi-Noori, S, Baras, A, Chua, A, Schrump, D S, Nguyen, D M
Publicado 2006